Key regions: United Kingdom, China, Europe, India, France
The demand for Other Vaccines in Hungary has been steadily increasing over the past few years.
Customer preferences: The Hungarian market for Other Vaccines is characterized by a high demand for vaccines that protect against infectious diseases such as hepatitis A, B, and C, as well as tetanus, diphtheria, and pertussis. These vaccines are often required by law for certain professions, such as healthcare workers, and are also recommended for travelers to certain destinations.
Trends in the market: One of the main trends driving the growth of the Other Vaccines market in Hungary is the increasing awareness of the importance of vaccination. The Hungarian government has been actively promoting vaccination campaigns and has implemented mandatory vaccination programs for children. In addition, the COVID-19 pandemic has also raised awareness about the importance of vaccination, leading to an increase in demand for Other Vaccines.Another trend in the market is the growing popularity of combination vaccines, which provide protection against multiple diseases in a single shot. This is particularly appealing to consumers who want to minimize the number of injections they receive.
Local special circumstances: Hungary has a well-established healthcare system, with a high level of access to healthcare services. The government provides universal healthcare coverage, which includes vaccination programs. This has contributed to the high demand for Other Vaccines in the country.
Underlying macroeconomic factors: The Hungarian economy has been growing steadily over the past few years, which has led to an increase in disposable income and a higher standard of living. This has allowed consumers to prioritize their health and wellbeing, which includes investing in preventative measures such as vaccination.In conclusion, the Other Vaccines market in Hungary is growing due to a combination of factors such as increasing awareness of the importance of vaccination, growing popularity of combination vaccines, a well-established healthcare system, and a growing economy.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
